In summary, the present study uncovers new insights that BAIBA could serve as a novel and potent therapeutic target for hypertension and its associated pathological vascular remodeling by activating the LKB1/AMPK/SIRT1 signaling pathway. Here, AGXT2 is linked to Hypertension.